LeMaitre Vascular, Inc. Share Price & Technical Analysis

LMAT · $97.75 (-1.78%)

Healthcare / Medical Instruments & Supplies

AI Score 32 · Bearish

$97.75

-1.78%

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arter

Price chart

Seasonality

May has 3 positive and 2 negative years (last 5 years shown)

-11% return in May, 9% avg return in past 3 year May month.

24% return in 2026, 25% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
265%27%3%0%-11%24%
255%-4%-9%8%-11%2%-2%18%-8%0%-4%-2%-6%
243%20%-5%-2%22%3%5%4%3%-5%20%-14%55%
232%6%3%5%16%7%-6%-8%-6%-11%10%9%27%
22-16%13%-2%-7%6%-1%10%-2%3%-15%8%-2%-5%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 32/100

Bearish · Emerging · Weak

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$2.26B

P/E ratio

36.35

52W high

$118.0

52W low

$78.35

Volume

1,99,037

Beta

0.60

Related stocks in Healthcare

Frequently asked questions

What is LeMaitre Vascular, Inc. share price today?
LeMaitre Vascular, Inc. (LMAT) last traded around $97.75 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does LMAT have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LMAT. Download the app for real-time alerts.
How can I analyze LeMaitre Vascular, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro